Loading...
Market
What will be the outcome of initial human trials of flying vaccinators by 2025?
2
Resolution / Starting Odds
Successful with no major issues • 25%
Successful but with minor issues • 25%
Unsuccessful with major issues • 25%
Inconclusive • 25%
Scientific journals or press releases from research institutions
Story
Bill Gates-Backed Researchers at Leiden University Use 'Flying Vaccinators' to Deliver Bioengineered Malaria-Causing Parasite
Dec 31, 2024, 06:00 PM
Researchers at Leiden University Medical Center, backed by the Bill Gates Foundation, have developed a new method for delivering malaria vaccines using genetically modified mosquitoes, referred to as 'flying vaccinators.' This innovative technique involves the mosquitoes injecting a bioengineered malaria-causing parasite into human test subjects. The study has raised significant safety and ethical concerns regarding the use of genetically modified organisms in vaccine delivery. The project has garnered attention due to its implications for public health and the potential risks associated with introducing genetically altered species into the environment.
View original story
Similar markets
Mostly Negative • 25%
Mostly Positive • 25%
Indifferent • 25%
Mixed • 25%
Efficacy above 90% • 25%
Efficacy below 50% • 25%
Efficacy between 50% and 75% • 25%
Efficacy between 75% and 90% • 25%
Successful with no adverse effects • 25%
Unsuccessful • 25%
Inconclusive • 25%
Successful but with some adverse effects • 25%
Pharmacies • 25%
Government clinics • 25%
Community centers • 25%
Private hospitals • 25%
Authorized with full approval • 25%
Authorized with emergency use • 25%
Not authorized • 25%
Authorization decision delayed • 25%